Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
853
-
Total 13F shares, excl. options
-
90M
-
Shares change
-
+2.87M
-
Total reported value, excl. options
-
$20.6B
-
Value change
-
+$632M
-
Put/Call ratio
-
3.86
-
Number of buys
-
423
-
Number of sells
-
-325
-
Price
-
$228.69
Significant Holders of RESMED INC - COM (RMD) as of Q4 2024
971 filings reported holding RMD - RESMED INC - COM as of Q4 2024.
RESMED INC - COM (RMD) has 853 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18.2M shares), BlackRock, Inc. (12.6M shares), STATE STREET CORP (6.47M shares), Bank of New York Mellon Corp (5.43M shares), GEODE CAPITAL MANAGEMENT, LLC (3.94M shares), MORGAN STANLEY (3.88M shares), Invesco Ltd. (2.33M shares), NORTHERN TRUST CORP (1.7M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (957K shares), and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (955K shares).
This table shows the top 853 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.